Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Year: 2008
Type: article
Study design: Clinical Trial
Source: Cancer Immunology Immunotherapy
Institutions: Centre Léon Bérard, Innate Pharma (France)
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Centre Léon Bérard
OpenAlex ID: W2043545955
